China Ministry of Health Report issue

Government Phase 2 Phase 3

Organization Overview

First Clinical Trial
2008
NCT00656253
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Alternative names

Beijing Hospital of the Ministry of Health

Active Ingredients

Drugs in Phase 3 Trials (2)

heshouwu (1 trial)

roucongrong (1 trial)

Drugs in Phase 2 Trials (1)

etoposide (vepesid) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 2)

Parkinson Disease (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3